BRAF and neoplasm: A meta-analysis of 2470 PTCs showed that BRAF mutant had a higher recurrence rate than BRAF wild type (24.9% vs. 12.6%), and its sensitivity for predicting tumor recurrence was 65%, indicating that BRAF mutation is closely related to tumor recurrence [50].